Falko Schmeisser

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi Incorporation of a lambda phage recombination system and EGFP detection to simplify mutagenesis of Herpes simplex virus bacterial artificial chromosomes
    Falko Schmeisser
    Laboratory of DNA Viruses, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    BMC Biotechnol 7:22. 2007
  2. ncbi Cloning of replication-incompetent herpes simplex viruses as bacterial artificial chromosomes to facilitate development of vectors for gene delivery into differentiated neurons
    Falko Schmeisser
    Laboratory of DNA Viruses, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Hum Gene Ther 17:93-104. 2006
  3. ncbi Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase
    Falko Schmeisser
    Division of Viral Products, Center for Biologics Evaluations and Research, Food and Drug Administration, Bethesda, MD 20892, United States
    Vaccine 30:3413-22. 2012
  4. ncbi Tetracycline-regulated gene expression in replication-incompetent herpes simplex virus vectors
    Falko Schmeisser
    Laboratory of DNA Viruses, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Hum Gene Ther 13:2113-24. 2002
  5. ncbi An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination
    Falko Schmeisser
    Division of Viral Products, Center for Biologics Evaluations and Research, Food and Drug Administration, 8800 Rockville Pike, Bethesda, MD 20892, United States
    Vaccine 28:2442-9. 2010
  6. ncbi DNA immunization with a herpes simplex virus 2 bacterial artificial chromosome
    Clement A Meseda
    Laboratory of DNA Viruses, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Virology 318:420-8. 2004

Detail Information

Publications6

  1. ncbi Incorporation of a lambda phage recombination system and EGFP detection to simplify mutagenesis of Herpes simplex virus bacterial artificial chromosomes
    Falko Schmeisser
    Laboratory of DNA Viruses, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    BMC Biotechnol 7:22. 2007
    ..While the BAC mutagenesis procedure is a powerful method to generate HSV-2 recombinants, particularly in the absence of selective marker in eukaryotic culture, the mutagenesis procedure is still difficult and cumbersome...
  2. ncbi Cloning of replication-incompetent herpes simplex viruses as bacterial artificial chromosomes to facilitate development of vectors for gene delivery into differentiated neurons
    Falko Schmeisser
    Laboratory of DNA Viruses, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Hum Gene Ther 17:93-104. 2006
    ..Thus, the BAC system provides a practicable platform for construction and manipulation of HSV vectors that are suitable for gene delivery into postmitotic neurons in vitro...
  3. ncbi Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase
    Falko Schmeisser
    Division of Viral Products, Center for Biologics Evaluations and Research, Food and Drug Administration, Bethesda, MD 20892, United States
    Vaccine 30:3413-22. 2012
    ..Mammalian derived VLPs may also provide a useful tool for studying virus-cell interactions and may have potential for development as pandemic vaccines...
  4. ncbi Tetracycline-regulated gene expression in replication-incompetent herpes simplex virus vectors
    Falko Schmeisser
    Laboratory of DNA Viruses, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Hum Gene Ther 13:2113-24. 2002
    ....
  5. ncbi An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination
    Falko Schmeisser
    Division of Viral Products, Center for Biologics Evaluations and Research, Food and Drug Administration, 8800 Rockville Pike, Bethesda, MD 20892, United States
    Vaccine 28:2442-9. 2010
    ....
  6. ncbi DNA immunization with a herpes simplex virus 2 bacterial artificial chromosome
    Clement A Meseda
    Laboratory of DNA Viruses, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Virology 318:420-8. 2004
    ..The results further suggest that such technology will be a powerful tool for dissecting the immune response to HSV-2...